Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve 1. The Unaudited Financial Statements (Standalone and Consolidated) for the Quarter and Half Year ended September 30, 2025;2. Consider the Limited Review Reports'' of the Statutory Auditor on Standalone and Consolidated Financial Statements for the Quarter and Half-Year ended September 30, 2025;3. Other Business items.